主營:染料與顏料 無機(jī)化工 催化劑及助劑 食品和飼料添加劑 石油化工 化學(xué)礦 化學(xué)試劑 信息化學(xué)品
VIP會員
|
>
品牌: |
未填 |
所在地: |
廣東 深圳市 |
起訂: |
≥1 件 |
供貨總量: |
1 件 |
有效期至: |
長期有效 |
簡介生物活性靶點體外研究體內(nèi)研究 用途與合成方法 MSDS 尿酸價格(試劑級) 上下游產(chǎn)品信息 專題
中文名稱 | 尿酸 |
---|---|
中文同義詞 | 尿酸;2,6,8-三羥基嘌呤;尿酸,標(biāo)準(zhǔn)液;尿酸,參比液;2,6,8,-三羥基尿雜環(huán);2,6,8,-三羥基嘌呤;尿酸(標(biāo)準(zhǔn)品);8-三羥基嘌呤 |
英文名稱 | Uric acid |
英文同義詞 | 1H-Purine-2,6,8(3H)-trione,7,9-dihydro-;1H-Purine-2,6,8-triol;2,6,8-Trioxopurine;6,8(3H)-trione,7,9-dihydro-1H-Purine-2;7,9-Dihydro-1H-purine-2,6,8(3H)-trione;8(3h)-trione,7,9-dihydro-1h-purine-6;Purine-3,6,8(1H,3H,9H)-trione;PURINE-2,6,8(1H,3H,9H)-TRIONE |
CAS號 | 69-93-2 |
分子式 | C5H4N4O3 |
分子量 | 168.11 |
EINECS號 | 200-720-7 |
相關(guān)類別 | 生化試劑;雜環(huán)砌塊;小分子抑制劑;有機(jī)砌塊;其他生化試劑;小分子抑制劑,天然產(chǎn)物;嘌呤;酸;細(xì)胞生物學(xué)-細(xì)胞氧化應(yīng)激;生化試劑-其他化學(xué)試劑;對照品;有機(jī)化工原料;Heterocycles;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Heterocycles, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals;Inhibitors;中藥對照品;化工原料 |
Mol文件 | 69-93-2.mol |
結(jié)構(gòu)式 | ![]() |
熔點 | >300 °C (lit.) |
---|---|
沸點 | 297.02°C (rough estimate) |
密度 | 1,9 g/cm3 |
折射率 | 1.9900 (estimate) |
儲存條件 | Sealed in dry,2-8°C |
溶解度 | 可溶于水基(少量加熱) |
酸度系數(shù)(pKa) | 3.89(at 12℃) |
形態(tài) | 結(jié)晶 |
顏色 | 白色至類白色 |
氣味 (Odor) | 無味 |
水溶解性 | Soluble in 1M sodium hydroxide solution. Slightly soluble in water. Insoluble in ether and alcohol. |
Merck | 14,9875 |
BRN | 156158 |
穩(wěn)定性 | 穩(wěn)定的。與酸、堿、氧化劑不相容。 |
LogP | -1.730 (est) |
CAS 數(shù)據(jù)庫 | 69-93-2(CAS DataBase Reference) |
EPA化學(xué)物質(zhì)信息 | Uric acid (69-93-2) |
簡介
尿酸是嘌呤代謝的終末產(chǎn)物,體內(nèi)總尿酸的80%由細(xì)胞核蛋白分解代謝產(chǎn)生,20%由攝入富含嘌呤的食物分解代謝產(chǎn)生。尿酸基本上以尿酸單鈉鹽的游離態(tài)形式存在于血液中,因此也稱為血尿酸。
生物活性
Uric acid 是一種內(nèi)源性抗氧化劑,可清除活性氧類化合物 (ROS),包括單線態(tài)氧,氧自由基和過氧亞硝酸鹽。
靶點
Human Endogenous Metabolite
|
體外研究
Uric acid is an endogenous antioxidant that scavenges reactive oxygen species (ROS) including singlet oxygen, oxygen radicals, and peroxynitrite. Incubation with indomethacin significantly increases malondialdehyde (MDA) levels in Caco-2 cells compare to those not treated indomethacin. Incubation with both indomethacin and Uric acid significantly decreases MDA levels compare to those grown in the presence of indomethacin alone. Co-treatment of cells with indomethacin and Uric acid significantly decreases ROS levels compare to those in cells incubated with indomethacin alone. Cell viability in Caco-2 cells treated with both indomethacin and Uric acid is higher than that in cells treated with indomethacin alone. Uric acid has a protective effect on indomethacin-induced intestinal cell changes through its antioxidant activity.
體內(nèi)研究
When mice treated with indomethacin are concurrently administered Uric acid orally, ulcer areas are significantly reduced, in a Uric acid dose-dependent manner. Indomethacin increases the ratio of crypt depth to villous height in the ileum, while the ratio is significantly lower when mice are concurrently administered Uric acid orally. Administration of indomethacin also increases the histopathological score of tissue damage in the small intestine, while mice concurrently administered Uric acid orally has a significantly lower histopathological score. The ileal levels of malondialdehyde (MDA) in indomethacin-induced enteropathy model mice orally administered Uric acid are also significantly lower than the levels in mice administered indomethacin alone.
用途
用作分析試劑,也用于有機(jī)合成
用途
用作測定尿酸的標(biāo)準(zhǔn)液
生產(chǎn)方法
1.取干燥雞糞懸浮于24倍量水中,加入適量氫氧化鈣后靜置。沉淀完全后分出上清液,沉淀中再加水,用硝酸調(diào)節(jié)pH值至3,靜置至沉淀完全。分出上清液,沉淀物再懸浮在水中,以氫氧化鈣調(diào)節(jié)pH值至12~12.5,過濾后濾液以硝酸調(diào)pH值至3,析出物過濾、干燥后即為尿酸粗品。
危險品標(biāo)志 | Xi |
---|---|
危險類別碼 | 33-36/37/38 |
安全說明 | 24/25-36-26 |
WGK Germany | 3 |
RTECS號 | YU7050080 |
TSCA | Yes |
海關(guān)編碼 | 29339900 |
毒性 | A nitrogenous end product and the principal excretory product of purine metabolism in mammals. In birds and reptiles, it is the principal end product of nitrogen metabolism in general. Defects in uric acid metabolism and excretion appear to be associated with a number of disease states, and it frequently occurs as a component of renal calculi. It has not been associated closely with toxic insults except in the case of lead poisoning. Lead causes an elevation in blood uric acid concentration (uric acidemia) and a decrease in uric acid excretion. |
提供商 | 語言 |
---|---|
SigmaAldrich | 英文 |
ACROS | 英文 |
ALFA | 中文 |
ALFA | 英文 |
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
---|---|---|---|---|---|
2024/08/19 | A13346 | 尿酸, 99% Uric acid, 99% | 69-93-2 | 25g | 517元 |
2024/08/19 | A13346 | 尿酸, 99% Uric acid, 99% | 69-93-2 | 100g | 1285元 |
下游產(chǎn)品
咖啡因次黃嘌呤三聚氰胺一酰胺縮三脲1,3,7-三甲基尿酸
還沒找到您需要的化玻儀器產(chǎn)品?立即發(fā)布您的求購意向,讓化玻儀器公司主動與您聯(lián)系!
立即發(fā)布求購意向本網(wǎng)頁所展示的有關(guān)【尿酸 CAS#: 69-93-2_化玻儀器_商品信息科技有限公司】的信息/圖片/參數(shù)等由云試劑的會員【商品信息科技有限公司】提供,由云試劑會員【商品信息科技有限公司】自行對信息/圖片/參數(shù)等的真實性、準(zhǔn)確性和合法性負(fù)責(zé),本平臺(本網(wǎng)站)僅提供展示服務(wù),請謹(jǐn)慎交易,因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決,本平臺(本網(wǎng)站)對此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁可以瀏覽【尿酸 CAS#: 69-93-2_化玻儀器_商品信息科技有限公司】有關(guān)的信息/圖片/價格等及提供【尿酸 CAS#: 69-93-2_化玻儀器_商品信息科技有限公司】的商家公司簡介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時,歡迎您向郵箱發(fā)送郵件,或者進(jìn)入《網(wǎng)站意見反饋》了解投訴處理流程,我們將竭誠為您服務(wù),感謝您對云試劑的關(guān)注與支持!